Development of Energetic Metabolism in Chronic Obstructive Pulmonary Disease Patients

LI Jian,LUO Yong,XU Wei-guo

DOI: https://doi.org/10.3760/cma.j.issn.1674-635x.2006.01.016

2006-01-01

Abstract:Nutritional therapy plays an active role in the management of chronic diseases such as chronic obstructive pulmonary diseases. This article summarized recent advances in studies on energetic metabolism,such as cytokine,hormone,and receptors.

What problem does this paper attempt to address?

The Effects of Nutritional Interventions on Energy Metabolism

Qian Tang,Hai Ning Yu,Sheng Rong Shen

DOI: https://doi.org/10.34175/jno202203002

2022-01-01

journal of nutritional oncology

Abstract:Energy metabolism is vital to the body's metabolic processes. A key player in the production of ATP, mitochondria directly affect energy homeostasis. Mitochondrial dysfunction is the cause of many diseases. Many reports have suggested that nutritional interventions can play a protective role against the development of mitochondrial dysfunction or in ameliorating existing dysfunction, such as by improving energy metabolism. This review focuses on the impact of different nutritional interventions on energy metabolism.
Progress in Nutritional Status and Therapy of Chronic Obstructive Pulmonary Disease

Yang Chengyu,Jin Meiling,Zhu Huili

DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2018.16.013

2018-01-01

Abstract:Chronic obstructive pulmonary disease (COPD) is a global health problem.Malnutrition is a common complication of COPD.Malnutrition affects lung function,quality of life and prognosis in COPD patients,and is also an independent risk factor for mortality.Through nutritional screening and assessment,nutritional status and metabolic phenotype can be determined.Proper nutritional intervention may improve the quality of life and prognosis of COPD patients.
Schinzel-Giedion syndrome with severe deafness and neurodegenerative process.

Y. Alembik,D. Christmann,A. D. S. Martin,M. Eliot,Hélène Dollfus,F. Pauly,C. Stoll

Abstract:A case of Schinzel-Giedion syndrome with a follow-up of two and a half years is reported. In addition to the classical features of the syndrome, the patient had severe hearing loss with ossicular and cochlear malformations, alacrymia, and progressive neurodegenerative disease.
The Role of Nutrition in the Development and Management of Chronic Obstructive Pulmonary Disease

Allison Heefner,Tijana Simovic,Kasey Mize,Paula Rodriguez-Miguelez

DOI: https://doi.org/10.3390/nu16081136

IF: 5.9

2024-04-11

Nutrients

Abstract:Chronic obstructive pulmonary disease (COPD) is a prevalent lung condition associated with significant morbidity and mortality. The management of COPD classically involves pulmonary rehabilitation, bronchodilators, and corticosteroids. An aspect of COPD management that is currently lacking in the literature is nutritional management, despite the prevalence of inadequate nutritional status in patients with COPD. In addition, certain nutritional imbalances have been reported to increase the risk of COPD development. This review summarizes the current literature on the role diet and nutrients may play in the risk and management of COPD development.
Lipid Metabolism In Chronic Obstructive Pulmonary Disease

Haipin Chen,Zhouyang Li,Lingling Dong,Yinfang Wu,Huahao Shen,Zhihua Chen

DOI: https://doi.org/10.2147/COPD.S196210

2019-01-01

Abstract:Dysregulated lipid metabolism plays crucial roles in various diseases, including diabetes mellitus, cancer, and neurodegeneration. Recent studies suggest that alterations in major lipid metabolic pathways contribute to pathogenesis of lung diseases, including chronic obstructive pulmonary disease (COPD). These changes allow lung tissue to meet the energy needs and trigger anabolic pathways that initiate the synthesis of active molecules directly involved in the inflammation. In this review, we summarize the changes of catabolism and anabolism of lipids, lipid molecules including lipid mediators, lipid synthesis transcription factors, cholesterol, and phospholipids, and how those lipid molecules participate in the initiation and resolution of inflammation in COPD.
The energy metabolism and body composition in chronic obstructive pulmonary disease patients

Zhi-qiang FAN,Hui-li ZHU

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2007.03.010

2007-01-01

Abstract:慢性阻塞性肺疾病(COPD)主要累及肺,但也可引起显著的全身效应,主要表现为全身性炎症反应和骨骼肌萎缩.本文主要综合了近年来国外有关COPD患者的能量代谢和人体成分的变化及其可能的机制方面的最新研究结果,同时对COPD营养干预的临床试验研究结果进行了总结,提出今后进一步探讨COPD患者营养不良发生机制和营养干预治疗的研究方向。
Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously

Li Wang,Xinyi Chen,Xiang Li,Dongli Liu,Xiaojun Wang,Xiaohong Chang,Youmin Guo

DOI: https://doi.org/10.1016/j.freeradbiomed.2021.03.039

IF: 8.101

2021-06-01

Free Radical Biology and Medicine

Abstract:<p>Chronic obstructive pulmonary disease (COPD) is estimated to be the sixth major cause of disability, and the third main cause of death in the world by 2020. Although both inflammation and oxidative stress are well known to be the key predisposing factors in the pathogenesis of COPD, other elements, including metabolism, may also contribute to the exacerbation of the disease. However, the therapeutic approach which alters metabolism against COPD has yet been fully developed. Therefore, here we provide a novel therapeutic strategy for COPD patients. We first screened out the known nuclear factor erythroid-2-related factor 2 (Nrf2) activators, CPUY192018, which inhibits glycolysis, boosts antioxidative stress simultaneously and delivers satisfying therapeutic effect in macrophages from COPD patients and cigarette smoke extract induced COPD mice. Furthermore, we clarify that CPUY192018 not only disrupts the interaction between Kelch-like ECH-associated protein 1 (Keap1) and Nrf2, which liberates Nrf2 to activate the antioxidative pathway but also disrupt the interaction between Keap1 and actin which downregulates glycolysis, boosting the phagocytic function of alveolar macrophage in lung tissue. Taken together, CPUY192018 demonstrates notable effects on counteracting oxidative stress and reprogramming metabolism via Nrf2 activation; hence, being a raising potential therapeutic approach against COPD.</p>

biochemistry & molecular biology,endocrinology & metabolism
Potential Micronutrients and Phytochemicals Against the Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer

Ting Zhai,Shizhen Li,Wei Hu,Duo Li,Shuguang Leng

DOI: https://doi.org/10.3390/nu10070813

IF: 5.9

2018-01-01

Nutrients

Abstract:Lung cancer and chronic obstructive pulmonary disease have shared etiology, including key etiological changes (e.g., DNA damage and epigenetics change) and lung function impairment. Focusing on those shared targets may help in the prevention of both. Certain micronutrients (vitamins and minerals) and phytochemicals (carotenoids and phenols) have potent antioxidant or methyl-donating properties and thus have received considerable interest. We reviewed recent papers probing into the potential of nutrients with respect to lung function preservation and prevention of lung cancer risk, and suggest several hypothetical intervention patterns. Intakes of vitamins (i.e., A, C, D, E, B12), carotenoids, flavonoids, curcumins, resveratrol, magnesium, and omega-3 fatty acids all show protective effects against lung function loss, some mainly by improving average lung function and others through reducing decline rate. Dietary interventions early in life may help lung function reserve over the lifespan. Protective nutrient interventions among smokers are likely to mitigate the effects of cigarettes on lung health. We also discuss their underlying mechanisms and some possible causes for the inconsistent results in observational studies and supplementation trials. The role of the lung microbiome on lung health and its potential utility in identifying protective nutrients are discussed as well. More prospective cohorts and well-designed clinical trials are needed to promote the transition of individualized nutrient interventions into health policy.
Exploring the Impact of Adequate Energy Supply on Nutrition, Immunity, and Inflammation in Elderly Patients with Chronic Obstructive Pulmonary Disease

Hui Gao,Xi Cheng,Xu Zuo,Zhaolan Huang

DOI: https://doi.org/10.2147/copd.s450209

2024-06-20

International Journal of COPD

Abstract:Hui Gao, 1 Xi Cheng, 1 Xu Zuo, 2 Zhaolan Huang 2 1 Department of General Practice, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei Province 430000, People's Republic of China; 2 Department of Respiratory and Digestive, Geriatric Hospital Affiliated with Wuhan University of Science and Technology, Wuhan, Hubei Province, 430000, People's Republic of China Correspondence: Zhaolan Huang, Department of Respiratory and Digestive, Geriatric Hospital Affiliated with Wuhan University of Science and Technology, No. 2, Huangjiahu West Road, Hongshan District, Wuhan, Hubei Province, 430000, People's Republic of China, Tel +86-19819051958, Email Background: Chronic Obstructive Pulmonary Disease (COPD) progression in the elderly is notably influenced by nutritional, immune, and inflammatory status. This study aimed to investigate the impact of adequate energy supply on these indicators in COPD patients. Methods: COPD patients meeting specific criteria were recruited and categorized into energy-adequate and energy-deficient groups based on their energy supply. Comparable demographic factors such as age, gender, smoking and drinking history, COPD duration, inhaled drug classification, and home oxygen therapy application were observed. Notable differences were found in BMI and inhaled drug use between the two groups. Results: The energy-adequate group exhibited significant improvements in various health indicators, including lymphocyte count, hemoglobin, CRP, total cholesterol, prealbumin, albumin, PNI, SII, SIRI, CAR, and CONUT scores in the secondary auxiliary examination. These positive changes suggest a notable enhancement in nutritional, immune, and inflammatory status. Conclusion: This research highlights the substantial benefits of adequate energy supply in elderly COPD patients. The observed improvements in nutritional, immune, and inflammatory markers underscore the importance of addressing energy needs to positively influence disease-related outcomes in this population. These findings have implications for developing targeted interventions to optimize the well-being of elderly individuals with COPD. Keywords: elderly, chronic obstructive pulmonary disease, energy supply, nutritional status, immune function, inflammatory response Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term encompassing various chronic respiratory conditions characterized by partially reversible airway limitation. Among its principal manifestations are chronic bronchitis and emphysema, as extensively discussed in recent literature. 1–3 COPD has become a pressing global public health concern, particularly due to its rising prevalence among the elderly population. The World Health Organization ranks COPD as the third leading cause of death worldwide. 4–6 Patients afflicted with COPD frequently present with chronic cough, sputum production, and respiratory distress, significantly diminishing their quality of life. 7,8 Furthermore, COPD often brings along a host of complications, including cardiovascular diseases, osteoporosis, and depression, adding to the complexity of patient care and management. 9–12 Recent studies have underscored the pivotal role of nutritional status in affecting the quality of life and survival rates of individuals with COPD. 13–16 In the realm of nutrition, suboptimal nutritional status has been linked to accelerated pulmonary function decline and an elevated risk of acute exacerbations. 17–19 Moreover, immune function plays a central role in the progression of COPD, with patients often experiencing heightened immune system activation, resulting in sustained inflammatory responses and airway remodeling. This systemic inflammation extends beyond the respiratory system, impacting other organ systems and giving rise to a myriad of complications. 20–22 Notably, despite the mounting evidence pointing to the association between nutrition and COPD, the specific role of energy supply in COPD management remains an understudied and insufficiently understood aspect. Adequate energy supply holds the potential to enhance patients' nutritional status and optimize their immune function, thereby reducing inflammatory responses and enhancing the quality of life among elderly COPD patients. 23,24 Furthermore, comprehending how energy supply influences the clinical manifestations and progression of COPD can provide valuable insights for optimizing COPD management and treatment strategies through nutritional intervention to enhance patient well-being. To bridge this knowledge gap and shed light on the impact of energy supply on COPD patients, we have selected key -Abstract Truncated-

respiratory system
[Nutritional Depletion in Chronic Obstructive Pulmonary Disease].

Yan Chen,Wan-zhen Yao

2004-01-01

Abstract:Chronic obstructive pulmonary disease (COPD) is one of the major diseases worldwide. Nutritional depletion is a common problem in COPD patients and also an independant predictor of survival in these patients. Many data are helpful for determining nutritional depletion, including anthropometric measurement, laboratory markers, body composition analysis (fat-free mass and lean mass), and body weight. The mechanism of nutritional depletion in patients with COPD is still uncertain. It may be associated with energy/metabolism imbalance, tissue hypoxia, systemic inflammation, and leptin/orexin disorders. In patients with nutritional depletion, growth hormone and testosterone can be used for nutritional therapy in addition to nutrition supplementation.
The efficacy of different training programs guided by cardiopulmonary exercise test goals for the treatment of male patients with chronic obstructive pulmonary disease

Hong Shen,Jinfeng Zhang,Fanghui Qiu,Yijie Dai,Jun Wang,Fu Tian

DOI: https://doi.org/10.22514/jomh.2023.093

2023-01-01

Journal of Men s Health

Abstract:To explore the therapeutic effect of aerobic exercise nursing plans based on target heart rate in cardiopulmonary exercise tests on male patients with chronic obstructive pulmonary disease. This study recruited 90 male patients with chronic obstructive pulmonary disease who met specific screening criteria and were evenly divided into a control group and an experimental group based on a random number table. The control group received respiratory training based on the target heart rate in the cardiopulmonary exercise test, while the experimental group received aerobic exercise based on the target heart rate in the cardiopulmonary exercise test. Both groups received 12 weeks of exercise each. Cardiopulmonary function tests showed that peak oxygen consumption (peak VO2), anaerobic threshold (AT), forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio in the test group were significantly higher than those in the control group (p < 0.05); furthermore, the carbon dioxide ventilation equivalent (VE/VCO2) slope was significantly lower than that in the control group (p < 0.05). The 6MWT of the test group was significantly higher than that in the control group (p < 0.05). The CAT score, Borg score and scores related to the symptoms, activities, and impacts related to quality-of-life were significantly reduced after intervention (p < 0.05). Aerobic exercise based on cardiopulmonary exercise testing can improve the health status, quality of life and prognosis of COPD patients.
Advances in nutritional metabolic therapy to impede the progression of critical illness

Wenwei Chen,Jia Song,Shijin Gong

DOI: https://doi.org/10.3389/fnut.2024.1416910

IF: 5

2024-07-06

Frontiers in Nutrition

Abstract:With the advancement of medical care and the continuous improvement of organ support technologies, some critically ill patients survive the acute phase of their illness but still experience persistent organ dysfunction, necessitating long-term reliance on intensive care and organ support, known as chronic critical illness. Chronic critical illness is characterized by prolonged hospital stays, high mortality rates, and significant resource consumption. Patients with chronic critical illness often suffer from malnutrition, compromised immune function, and poor baseline health, which, combined with factors like shock or trauma, can lead to intestinal mucosal damage. Therefore, effective nutritional intervention for patients with chronic critical illness remains a key research focus. Nutritional therapy has emerged as one of the essential components of the overall treatment strategy for chronic critical illness. This paper aims to provide a comprehensive review of the latest research progress in nutritional support therapy for patients with chronic critical illness.

nutrition & dietetics
Metabolic Reprogramming in the Pathogenesis of Chronic Lung Diseases, Including BPD, COPD, and Pulmonary Fibrosis.

Haifeng Zhao,Phyllis A. Dennery,Hongwei Yao

DOI: https://doi.org/10.1152/ajplung.00521.2017

2018-01-01

Abstract:The metabolism of nutrient substrates, including glucose, glutamine, and fatty acids, provides acetyl-CoA for the tricarboxylic acid cycle to generate energy, as well as metabolites for the biosynthesis of biomolecules, including nucleotides, proteins, and lipids. It has been shown that metabolism of glucose, fatty acid, and glutamine plays important roles in modulating cellular proliferation, differentiation, apoptosis, autophagy, senescence, and inflammatory responses. All of these cellular processes contribute to the pathogenesis of chronic lung diseases, including bronchopulmonary dysplasia, chronic obstructive pulmonary disease, and pulmonary fibrosis. Recent studies demonstrate that metabolic reprogramming occurs in patients with and animal models of chronic lung diseases, suggesting that metabolic dysregulation may participate in the pathogenesis and progression of these diseases. In this review, we briefly discuss the catabolic pathways for glucose, glutamine, and fatty acids, and focus on how metabolic reprogramming of these pathways impacts cellular functions and leads to the development of these chronic lung diseases. We also highlight how targeting metabolic pathways can be utilized in the prevention and treatment of these diseases.
Metabolic reprogramming in the pathogenesis of chronic lung diseases including BPD, COPD, and pulmonary fibrosis.

Haifeng Zhao,Phyllis A Dennery,Hongwei Yao

DOI: https://doi.org/10.1152/ajplung.00521.2017

2018-01-01

Abstract:The metabolism of nutrient substrates, including glucose, glutamine, and fatty acids, provides acetyl-CoA for the tricarboxylic acid cycle to generate energy, as well as metabolites for the biosynthesis of biomolecules, including nucleotides, proteins, and lipids. It has been shown that metabolism of glucose, fatty acid, and glutamine plays important roles in modulating cellular proliferation, differentiation, apoptosis, autophagy, senescence, and inflammatory responses. All of these cellular processes contribute to the pathogenesis of chronic lung diseases, including bronchopulmonary dysplasia, chronic obstructive pulmonary disease, and pulmonary fibrosis. Recent studies demonstrate that metabolic reprogramming occurs in patients with and animal models of chronic lung diseases, suggesting that metabolic dysregulation may participate in the pathogenesis and progression of these diseases. In this review, we briefly discuss the catabolic pathways for glucose, glutamine, and fatty acids, and focus on how metabolic reprogramming of these pathways impacts cellular functions and leads to the development of these chronic lung diseases. We also highlight how targeting metabolic pathways can be utilized in the prevention and treatment of these diseases.
Cellular and Molecular Biology of Mitochondria in Chronic Obstructive Pulmonary Disease

Chin-Ling Li,Shih-Feng Liu

DOI: https://doi.org/10.3390/ijms25147780

2024-07-16

Abstract:Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by enduring airflow limitation and chronic inflammation. Growing evidence highlights mitochondrial dysfunction as a critical factor in COPD development and progression. This review explores the cellular and molecular biology of mitochondria in COPD, focusing on structural and functional changes, including alterations in mitochondrial shape, behavior, and respiratory chain complexes. We discuss the impact on cellular signaling pathways, apoptosis, and cellular aging. Therapeutic strategies targeting mitochondrial dysfunction, such as antioxidants and mitochondrial biogenesis inducers, are examined for their potential to manage COPD. Additionally, we consider the role of mitochondrial biomarkers in diagnosis, evaluating disease progression, and monitoring treatment efficacy. Understanding the interplay between mitochondrial biology and COPD is crucial for developing targeted therapies to slow disease progression and improve patient outcomes. Despite advances, further research is needed to fully elucidate mitochondrial dysfunction mechanisms, discover new biomarkers, and develop targeted therapies, aiming for comprehensive disease management that preserves lung function and enhances the quality of life for COPD patients.
Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Unraveling the Molecular Nexus

Chin-Ling Li,Jui-Fang Liu,Shih-Feng Liu

DOI: https://doi.org/10.3390/biomedicines12040814

IF: 4.757

2024-04-08

Biomedicines

Abstract:Chronic obstructive pulmonary disease (COPD) is a prevalent and debilitating respiratory disorder characterized by persistent airflow limitation and chronic inflammation. In recent years, the role of mitochondrial dysfunction in COPD pathogenesis has emerged as a focal point of investigation. This review endeavors to unravel the molecular nexus between mitochondrial dysfunction and COPD, delving into the intricate interplay of oxidative stress, bioenergetic impairment, mitochondrial genetics, and downstream cellular consequences. Oxidative stress, a consequence of mitochondrial dysfunction, is explored as a driving force behind inflammation, exacerbating the intricate cascade of events leading to COPD progression. Bioenergetic impairment sheds light on the systemic consequences of mitochondrial dysfunction, impacting cellular functions and contributing to the overall energy imbalance observed in COPD patients. This review navigates through the genetic landscape, elucidating the role of mitochondrial DNA mutations, variations, and haplogroups in COPD susceptibility and severity. Cellular consequences, including apoptosis, autophagy, and cellular senescence, are examined, providing insights into the intricate mechanisms by which mitochondrial dysfunction influences COPD pathology. Therapeutic implications, spanning antioxidant strategies, mitochondria-targeted compounds, and lifestyle modifications, are discussed in the context of translational research. Important future directions include identifying novel biomarkers, advancing mitochondria-targeted therapies, and embracing patient-centric approaches to redefine COPD management. This abstract provides a comprehensive overview of our review, offering a roadmap for understanding and addressing the molecular nexus between mitochondrial dysfunction and COPD, with potential implications for precision medicine and improved patient outcomes.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
The human body as an energetic hybrid? New perspectives for chronic disease treatment?

Michał Gajewski,Przemysław Rzodkiewicz,Sławomir Maśliński

DOI: https://doi.org/10.5114/reum.2017.67605

2017-01-01

Reumatologia/Rheumatology

Abstract:Inflammatory response is accompanied by changes in cellular energy metabolism. Proinflammatory mediators like plasma C-reactive protein, IL-6, plasminogen activator inhibitor-1, TNF-α or monocyte chemoattractant protein-1 released in the site of inflammation activates immune cells and increase energy consumption. Increased demand for energy creates local hypoxia and lead in consequence to mitochondrial dysfunction. Metabolism of cells is switched to anaerobic glycolysis. Mitochondria continuously generate free radicals that what result in imbalance that causes oxidative stress, which results in oxidative damage. Chronic energy imbalance promotes oxidative stress, aging, and neurodegeneration and is associated with numerous disorders like Alzheimer's disease, multiple sclerosis, Parkinson's disease or Huntington's disease. It is also believed that oxidative stress and the formation of free radicals play an important role in the pathogenesis of rheumatoid diseases including especially rheumatoid arthritis. Pharmacological control of energy metabolism disturbances may be valuable therapeutic strategy of treatment of this disorders. In recent review we sum up knowledge related to energy disturbances and discuss phenomena such as zombies or hibernation which may indicate the potential targets for regulation of energy metabolism.
Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics

Wen-cheng Zhou,Jiao Qu,Sheng-yang Xie,Yang Sun,Hong-wei Yao

DOI: https://doi.org/10.1155/2021/5188306

2021-07-27

Oxidative Medicine and Cellular Longevity

Abstract:Mitochondria are indispensable for energy metabolism and cell signaling. Mitochondrial homeostasis is sustained with stabilization of mitochondrial membrane potential, balance of mitochondrial calcium, integrity of mitochondrial DNA, and timely clearance of damaged mitochondria via mitophagy. Mitochondrial dysfunction is featured by increased generation of mitochondrial reactive oxygen species, reduced mitochondrial membrane potential, mitochondrial calcium imbalance, mitochondrial DNA damage, and abnormal mitophagy. Accumulating evidence indicates that mitochondrial dysregulation causes oxidative stress, inflammasome activation, apoptosis, senescence, and metabolic reprogramming. All these cellular processes participate in the pathogenesis and progression of chronic respiratory diseases, including chronic obstructive pulmonary disease, pulmonary fibrosis, and asthma. In this review, we provide a comprehensive and updated overview of the impact of mitochondrial dysfunction on cellular processes involved in the development of these respiratory diseases. This not only implicates mechanisms of mitochondrial dysfunction for the pathogenesis of chronic lung diseases but also provides potential therapeutic approaches for these diseases by targeting dysfunctional mitochondria.

cell biology
Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview

Liu-Ying Li,Chuan-Tao Zhang,Feng-Ya Zhu,Gang Zheng,Yu-Fei Liu,Ke Liu,Chen-Hui Zhang,Hong Zhang

DOI: https://doi.org/10.3389/fphar.2022.821941

IF: 5.6

2022-03-24

Frontiers in Pharmacology

Abstract:Chronic obstructive pulmonary disease (COPD) is one of the major diseases threatening human life and health. According to the report released by the World Health Organization (WHO) in 2020, COPD has become the third leading cause of death in the world, featuring a sustainable growth of incidence rate as well as population age. The purpose of this review focuses on the advancement of bioactive natural compounds, such as baicalin, quercetin, resveratrol, and curcumin, which demonstrate promising therapeutic/interventional effects on CODP in vitro and in vivo . Information emphasizing on COPD was systematically collected from several authoritative internet databases including Web of Science, PubMed, Elsevier, Wiley Online Library, and Europe PMC, with a combination of keywords containing “COPD” and “natural small molecular compounds”. The new evidence indicated that these valuable molecules featured unique functions in the treatment of COPD through various biological processes such as anti-inflammatory, anti-oxidant, anti-apoptosis, and anti-airway fibrosis. Moreover, we found that the promising effects of these natural compounds on COPD were mainly achieved through JAK3/STAT3/NF-κB and MAPK inflammatory signaling pathways, Nrf2 oxidative stress signaling pathway, and TGF-β1/Smad 2/3 fibrosis signaling pathway, which referenced to multiple targets like TNF-α, IL-6, IL-8, TIMP-1, MMP, AKT, JAK3, IKK, PI3K, HO-1, MAPK, P38, ERK, etc. Current challenges and future directions in this promising field are also discussed at the end of this review. For the convenience of the readers, this review is divided into ten parts according to the structures of potential natural small molecular compounds. We hope that this review brings a quick look and provides some inspiration for the research of COPD.

pharmacology & pharmacy
Copd_a_196210 1009..1018

Haipin Chen,Zhouyang Li,Lingling Dong,Yinfang Wu,Huahao Shen,Zhihua Chen

2019-01-01

Abstract:1Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Institute of Respiratory Diseases, Hangzhou, Zhejiang, People’s Republic of China; 2State Key Lab of Respiratory Disease, Guangzhou, Guangdong, People’s Republic of China Abstract: Dysregulated lipid metabolism plays crucial roles in various diseases, including diabetes mellitus, cancer, and neurodegeneration. Recent studies suggest that alterations in major lipid metabolic pathways contribute to pathogenesis of lung diseases, including chronic obstructive pulmonary disease (COPD). These changes allow lung tissue to meet the energy needs and trigger anabolic pathways that initiate the synthesis of active molecules directly involved in the inflammation. In this review, we summarize the changes of catabolism and anabolism of lipids, lipid molecules including lipid mediators, lipid synthesis transcription factors, cholesterol, and phospholipids, and how those lipid molecules participate in the initiation and resolution of inflammation in COPD.

Development of Energetic Metabolism in Chronic Obstructive Pulmonary Disease Patients

The Effects of Nutritional Interventions on Energy Metabolism

Progress in Nutritional Status and Therapy of Chronic Obstructive Pulmonary Disease

Schinzel-Giedion syndrome with severe deafness and neurodegenerative process.

The Role of Nutrition in the Development and Management of Chronic Obstructive Pulmonary Disease

Lipid Metabolism In Chronic Obstructive Pulmonary Disease

The energy metabolism and body composition in chronic obstructive pulmonary disease patients

Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously

Potential Micronutrients and Phytochemicals Against the Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer

Exploring the Impact of Adequate Energy Supply on Nutrition, Immunity, and Inflammation in Elderly Patients with Chronic Obstructive Pulmonary Disease

[Nutritional Depletion in Chronic Obstructive Pulmonary Disease].

The efficacy of different training programs guided by cardiopulmonary exercise test goals for the treatment of male patients with chronic obstructive pulmonary disease

Advances in nutritional metabolic therapy to impede the progression of critical illness

Metabolic Reprogramming in the Pathogenesis of Chronic Lung Diseases, Including BPD, COPD, and Pulmonary Fibrosis.

Metabolic reprogramming in the pathogenesis of chronic lung diseases including BPD, COPD, and pulmonary fibrosis.

Cellular and Molecular Biology of Mitochondria in Chronic Obstructive Pulmonary Disease

Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Unraveling the Molecular Nexus

The human body as an energetic hybrid? New perspectives for chronic disease treatment?

Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview

Copd_a_196210 1009..1018